BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19231538)

  • 21. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
    Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
    Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
    Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
    Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.
    Warmann S; Hunger M; Teichmann B; Flemming P; Gratz KF; Fuchs J
    Cancer; 2002 Oct; 95(8):1795-801. PubMed ID: 12365029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
    Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
    Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma.
    Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J
    Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs.
    Sánchez C; Mendoza P; Contreras HR; Vergara J; McCubrey JA; Huidobro C; Castellón EA
    Prostate; 2009 Sep; 69(13):1448-59. PubMed ID: 19496068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interaction of WAVE1 and genes involved in multiple drug resistance in children with acute myeloblastic leukemia].
    Yang MH; Zhao MY; He YL; Wang MH; Wang Z; Xie M; Wu XS; Cao LZ
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):175-9. PubMed ID: 20426950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations.
    Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V; Beck JF
    Anticancer Res; 2002; 22(6C):4229-32. PubMed ID: 12553062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
    Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expressions of LRP, GST-pi and MRP1 in acute leukemia patients and its clinical significance].
    Huang BT; Xiao Z; Shi YT; Ha S; Zhao WH; Gao D; Yan XH; Yang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):262-6. PubMed ID: 17493328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
    Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
    Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL; Zhai HY; Chen BY; Zhai SP; Yang HY; Chen XP; Zhao WT; Meng L
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):296-9. PubMed ID: 15138130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma.
    Gallego S; Llort A; Parareda A; Sanchez De Toledo J
    Oncol Rep; 2004 Jan; 11(1):179-83. PubMed ID: 14654923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer.
    Obata H; Yahata T; Quan J; Sekine M; Tanaka K
    Anticancer Res; 2006; 26(3B):2227-32. PubMed ID: 16821592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance proteins in renal cell carcinoma.
    Hodorová I; Rybárová S; Solár P; Vecanová J; Mihalik J; Bohus P; Mellová Y; Kluchová D
    Folia Biol (Praha); 2008; 54(6):187-92. PubMed ID: 19393132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma.
    Ohsawa M; Ikura Y; Fukushima H; Shirai N; Sugama Y; Suekane T; Hirayama M; Hino M; Ueda M
    Oncology; 2005; 68(4-6):422-31. PubMed ID: 16020972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.